IL310580A - Raloxifene לשימוש בטיפול בזיהומים מסוג sars-cov-2 - Google Patents
Raloxifene לשימוש בטיפול בזיהומים מסוג sars-cov-2Info
- Publication number
- IL310580A IL310580A IL310580A IL31058024A IL310580A IL 310580 A IL310580 A IL 310580A IL 310580 A IL310580 A IL 310580A IL 31058024 A IL31058024 A IL 31058024A IL 310580 A IL310580 A IL 310580A
- Authority
- IL
- Israel
- Prior art keywords
- cov
- sars
- raloxifene
- infections
- variants
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title 1
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 title 1
- 229960004622 raloxifene Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21189699.8A EP4129287A1 (en) | 2021-08-04 | 2021-08-04 | Raloxifene for use in the treatment of sars-cov-2 variants infections |
| PCT/EP2022/071862 WO2023012233A1 (en) | 2021-08-04 | 2022-08-03 | Raloxifene for use in the treatment of sars-cov-2 variants infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL310580A true IL310580A (he) | 2024-03-01 |
Family
ID=77226603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL310580A IL310580A (he) | 2021-08-04 | 2022-08-03 | Raloxifene לשימוש בטיפול בזיהומים מסוג sars-cov-2 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240342150A1 (he) |
| EP (2) | EP4129287A1 (he) |
| JP (1) | JP2024528283A (he) |
| AU (1) | AU2022321982A1 (he) |
| CA (1) | CA3228247A1 (he) |
| IL (1) | IL310580A (he) |
| WO (1) | WO2023012233A1 (he) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021187670A1 (ko) * | 2020-03-18 | 2021-09-23 | 재단법인 경기도경제과학진흥원 | 랄록시펜을 이용한 코로나바이러스 감염증 개선용 조성물 |
| US20230147364A1 (en) * | 2020-04-30 | 2023-05-11 | Kyoto University | Prophylactic or therapeutic agent for rna virus-related diseases |
| CN111728973A (zh) * | 2020-05-27 | 2020-10-02 | 中国医学科学院病原生物学研究所 | 抗新型冠状病毒SARS-CoV-2的药物及其应用 |
-
2021
- 2021-08-04 EP EP21189699.8A patent/EP4129287A1/en not_active Withdrawn
-
2022
- 2022-08-03 US US18/294,660 patent/US20240342150A1/en active Pending
- 2022-08-03 AU AU2022321982A patent/AU2022321982A1/en active Pending
- 2022-08-03 IL IL310580A patent/IL310580A/he unknown
- 2022-08-03 EP EP22760944.3A patent/EP4380568A1/en not_active Withdrawn
- 2022-08-03 CA CA3228247A patent/CA3228247A1/en active Pending
- 2022-08-03 WO PCT/EP2022/071862 patent/WO2023012233A1/en not_active Ceased
- 2022-08-03 JP JP2024507135A patent/JP2024528283A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023012233A1 (en) | 2023-02-09 |
| AU2022321982A1 (en) | 2024-02-22 |
| EP4129287A1 (en) | 2023-02-08 |
| JP2024528283A (ja) | 2024-07-26 |
| EP4380568A1 (en) | 2024-06-12 |
| US20240342150A1 (en) | 2024-10-17 |
| CA3228247A1 (en) | 2023-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL278178A (he) | שימוש בפילוקרפין הידרוכלוריד לטיפול בהפרעול עיניות | |
| PL3972643T3 (pl) | Antagoniści układu dopełniacza do stosowania w sposobach leczenia neuropatii paraproteinemicznych | |
| IL277238A (he) | אוליגונוקליאוטידים שעברו שינוי לשימוש בטיפול בטאופתיות | |
| PL4076461T3 (pl) | Lumateperon do stosowania w leczeniu schizofrenii | |
| IL288861A (he) | תרופה ושימוש בה לטיפול בזיהומים בקטריאליים הקשורים לביופילם | |
| GB202416189D0 (en) | Methods for the prophylaxis and treatment of Covid and Covid-19 | |
| ZA202307970B (en) | Compounds for use in the treatment and prevention of covid- 19 | |
| IL289371A (he) | מתילתיוניניום לשימוש בטיפול בסינפטופתיות | |
| SMT202500434T1 (it) | Sotorasib per l'uso nel trattamento del cancro | |
| IL278895A (he) | דילטיאזם לשימוש בטיפול בזיהומים מיקרוביאלים | |
| GB2595513B (en) | Treatment of infections | |
| IL312885A (he) | ניטרוקסולין לשימוש בטיפול או מניעה של פלקסיפורם ניורופיברומה | |
| SG11202102790PA (en) | Indane derivatives for use in the treatment of bacterial infection | |
| IL286818A (he) | מיריקיזומאב לשימוש בשיטה לטיפול במחלת קרוהן | |
| IL282718A (he) | תרכובות לשימוש בטיפול או מניעת כאב, דלקת ו/או מחלות אוטואימוניות | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| IL310580A (he) | Raloxifene לשימוש בטיפול בזיהומים מסוג sars-cov-2 | |
| GB202003722D0 (en) | Treatment | |
| PL4288547T3 (pl) | Aptamery do stosowania w leczeniu zakażeń coronaviridae | |
| GB202002299D0 (en) | Agents for use in the treatment of tissue damage | |
| GB202002711D0 (en) | Treatment | |
| GB201918539D0 (en) | Compounds for use in treatment and prophylaxis | |
| GB202019762D0 (en) | Compounds for use in treatment and prophylaxis | |
| GB202302121D0 (en) | Compounds for use in the treatment of schizophrenia | |
| ZA202005856B (en) | Treatment of infections |